share_log

Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D

SEC ·  Jun 21, 2024 01:56
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more